Skip to main content
Year archive

NEXALIS THERAPEUTICS LTD — 2024 filings

All 59 regulatory filings released by NEXALIS THERAPEUTICS LTD (NX1) in 2024, sourced directly from the official regulator.

59 Filings
2024 Period
2024 filings (59)
Filing Released Lang
Shareholder Update 4 pages 201.2KB
Regulatory Filings
2024-12-18 English
Notification of cessation of securities - IRX 4 pages 14.8KB
Share Issue/Capital Change
2024-12-16 English
Application for quotation of securities - IRX 6 pages 18.3KB
Share Issue/Capital Change
2024-12-16 English
Change of Director's Interest Notice - Sean Williams 2 pages 307.9KB
Director's Dealing
2024-12-16 English
Change of Director's Interest Notice - James Barrie 2 pages 283.5KB
Director's Dealing
2024-12-16 English
Cleansing Notice 1 page 176.7KB
Share Issue/Capital Change
2024-12-16 English
Issue of Securities Following General Meeting Approval 1
Capital/Financing Update
2024-12-15 English
Notification regarding unquoted securities - IRX 6 pages 20.1KB
Share Issue/Capital Change
2024-12-15 English
Proposed issue of securities - IRX 5 pages 17.5KB
Capital/Financing Update
2024-12-15 English
Results of General Meeting 2 pages 258.1KB
Declaration of Voting Results & Voting Rights Announcements
2024-11-28 English
Director Appointment and Resignation 6 pages 417.9KB
Board/Management Information
2024-11-27 English
Nov24 EGM Slides 30 pages 2.4MB
Declaration of Voting Results & Voting Rights Announcements
2024-11-27 English
Ethics Approval for Phase 2 Clinical Trial of IRX-211 3 pages 188.6KB
Regulatory Filings
2024-11-14 English
Change in substantial holding - Cannvalate 3 pages 220.6KB
Major Shareholding Notification
2024-11-13 English
Sep24 Quarterly Activities Report 7 pages 281.0KB
Interim / Quarterly Report
2024-10-30 English
Sep24 Appendix 4C Cash Flow Report 6 pages 312.8KB
Interim / Quarterly Report
2024-10-30 English
General Meeting - Sample Proxy 2 pages 197.9KB
Proxy Solicitation & Information Statement
2024-10-28 English
Notice of General Meeting 24 pages 449.6KB
Proxy Solicitation & Information Statement
2024-10-28 English
General Meeting - Access Letter 1 page 123.7KB
AGM Information
2024-10-28 English
Change in substantial holding 4 pages 1.1MB
Regulatory Filings
2024-10-27 English
Application for quotation of securities - IRX 6 pages 18.4KB
Share Issue/Capital Change
2024-10-23 English
Proposed issue of securities - IRX 5 pages 17.4KB
Capital/Financing Update
2024-10-22 English
Issue of Loan Conversion shares 2 pages 190.6KB
Capital/Financing Update
2024-10-22 English
Cleansing Notice 1 page 175.9KB
Share Issue/Capital Change
2024-10-22 English
$38.5m Funding to Fully Fund Clinical Development Plans 10 pages 397.9KB
Capital/Financing Update
2024-10-17 English
Proposed issue of securities - IRX 5 pages 19.7KB
Capital/Financing Update
2024-10-17 English
Application for quotation of securities - IRX 6 pages 18.4KB
Share Issue/Capital Change
2024-10-02 English
Issue of Shares to CEO in Lieu of Accrued Salary 1
Share Issue/Capital Change
2024-10-01 English
Proposed issue of securities - IRX 5 pages 17.2KB
Capital/Financing Update
2024-10-01 English
Half Yearly Report and Accounts 19 pages 962.4KB
Interim / Quarterly Report
2024-08-29 English
Jun24 Appendix 4C Cash Flow Report 5 pages 315.7KB
Interim / Quarterly Report
2024-07-30 English
Jun24 Quarterly Activities Report 4 pages 241.6KB
Interim / Quarterly Report
2024-07-30 English
Live Investor Webinar 19 pages 3.7MB
Investor Presentation
2024-07-24 English
IRX616a IND Application Outcome 2 pages 180.0KB
Regulatory Filings
2024-07-04 English
Final Clinical Study Report Received, Phase 1 IRX-211 2 pages 179.6KB
Regulatory Filings
2024-07-02 English
Change of Director's Interest Notice - Sean Williams 2 pages 307.7KB
Director's Dealing
2024-06-05 English
Notification regarding unquoted securities - IRX 7 pages 21.5KB
Share Issue/Capital Change
2024-06-02 English
AGM Results 2 pages 248.0KB
Declaration of Voting Results & Voting Rights Announcements
2024-05-30 English
Significant Milestone - IND submitted to the FDA for IRX616a 2 pages 198.7KB
Regulatory Filings
2024-05-29 English
2024 AGM Slides 33 pages 1.6MB
AGM Information
2024-05-29 English
Notice of Annual General Meeting 49 pages 1.3MB
AGM Information
2024-04-29 English
AGM Sample Proxy Form 2 pages 557.3KB
Regulatory Filings
2024-04-29 English
AGM Access Letter 1 page 133.4KB
AGM Information
2024-04-29 English
Mar24 Quarterly Activities Report 4 pages 252.5KB
Interim / Quarterly Report
2024-04-29 English
Mar24 Appendix 4C Cash Flow Report 6 pages 320.9KB
Interim / Quarterly Report
2024-04-29 English
Change of Registered Office Address 1 page 178.9KB
Regulatory Filings
2024-04-17 English
$500,000 Convertible Loan Facility 2 pages 184.7KB
Capital/Financing Update
2024-03-27 English
Annual Report to shareholders 43 pages 784.4KB
Annual Report
2024-03-27 English
Corporate Governance Statement and Appendix 4G 18 pages 336.9KB
Governance Information
2024-03-27 English
Appendix 4G 12 pages 395.7KB
Governance Information
2024-03-27 English
Proposed issue of securities - IRX 7 pages 25.8KB
Capital/Financing Update
2024-03-27 English
Shareholder Town Hall Webinar Slides 18 pages 7.4MB
Investor Presentation
2024-03-19 English
Shareholder Townhall Webinar - Wed 20 Mar 2024 at 1.30pm 2 pages 218.1KB
Investor Presentation
2024-03-12 English
Milestone achieved - Database Lock Phase 1 IRX211 4 pages 218.1KB
Regulatory Filings
2024-03-05 English
Director Appointment and Resignation 5 pages 391.7KB
Board/Management Information
2024-02-29 English
Preliminary Final Report 11 pages 758.8KB
Annual Report
2024-02-13 English
Dec23 Quarterly Activities Report 6 pages 261.2KB
Interim / Quarterly Report
2024-01-15 English
Dec23 Appendix 4C Cash Flow Report 5 pages 269.5KB
Interim / Quarterly Report
2024-01-15 English
IRX211 - Targeted Pain Indication Nomination - BTcP 4 pages 251.2KB
Regulatory Filings
2024-01-09 English